BNT162b2 Vaccination during Pregnancy Protects Both the Mother and Infant: Anti-SARS-CoV-2 S Antibodies Persistently Positive in an Infant at 6 Months of AgeCase Report Published on 2021-10-122022-10-31 Journal: Case Reports in Pediatrics [Category] COVID-19, [키워드] age Anti-SARS-CoV-2 S antibody Antibody titer BNT162b2 BNT162b2 vaccine Case report caused children Complication complications coronavirus disease COVID-19 COVID-19 antibody declining dose gestation help immune response Infant Influenza Intervention Month mother mRNA-based vaccine Newborn Other pandemic Pregnancy Prevent PROTECT recent reduced Safe SARS-COV-2 infection shown the SARS-CoV-2 virus vaccination Vaccines [DOI] 10.1155/2021/6901131 PMC 바로가기 [Article Type] Case Report
BNT162b2 mRNA Vaccination Leads to Long-Term Protection from COVID-19 DiseaseCommunication Published on 2021-10-122022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] Administered administration anti-S1 IgG antibody BNT162b2 BNT162b2 mRNA CD4+ CD8+ cellular immunity changes in consolidation COVID-19 COVID-19 disease Efficacy knowledge memory cell Memory cells mRNA-based vaccine neutralizing antibody persistence PROTECT protection replaced resulting SARS-CoV-2 SARS-COV-2 infection severe adverse effect spike-specific T-cells subject T-cells vaccination vaccine dose Vaccines Variability [DOI] 10.3390/vaccines9101164 PMC 바로가기 [Article Type] Communication
Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis PatientCase Report Published on 2021-10-062022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] administration anti-S IgG Anti-spike Antibody Response BNT162b2 BNT162b2 vaccine ChAdOx1 ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 vaccine drug Heterologous humoral immune response induced mRNA BNT162b2 mRNA-based vaccine Multiple multiple sclerosis Neutralizing antibody response Patient Prevent protein S protocol regimen response SARS-CoV-2 SARS-CoV-2 vaccination sclerosis Teriflunomide treated vaccination Vaccine viral vector-based [DOI] 10.3390/vaccines9101140 PMC 바로가기 [Article Type] Case Report
Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several DaysImmunology Published on 2021-10-042022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] absence analyzed antibody B-cell BNT162b2 cellular cellular immune responses comparable COVID-19 cytokine Day disease effective Efficacy explain healthy humoral immune response Immunity immunization induce induction Infection infection risk Level medication Mortality mRNA mRNA-1273 mRNA-1273 vaccine mRNA-based vaccine mRNA-vaccines objective pandemic Prevent Prophylactic Protective protective immunity provide receiving reduce required response Result robust SARS – CoV – 2 SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 peptide SARS-CoV-2-specific T cell second dose secreted Specific specific humoral response Specific T-cell response spike-specific IgG T cell T-cell Response T-cell responses the disease the spike protein the vaccine Treatment unique vaccination vaccination schedule Vaccine Volunteer Whole blood [DOI] 10.3389/fimmu.2021.726960 PMC 바로가기 [Article Type] Immunology
Axonal-Variant Guillian-Barre Syndrome Temporally Associated With mRNA-Based Moderna SARS-CoV-2 VaccineNeurology Published on 2021-09-262022-10-31 Journal: Cureus [Category] COVID-19, [키워드] adverse event appear association cerebrospinal fluid clinical symptom COVID-19 CSF Diagnosis effective Epidemiological study Evidence gbs following covid-19 vaccine gbs variant IMPROVE Infection prevention Moderna mRNA-1273 vaccine mRNA-based mRNA-based SARS-CoV-2 vaccine mRNA-based vaccine outcomes physician SARS-CoV-2 SARS-CoV-2 vaccine second dose Treatment [DOI] 10.7759/cureus.18291 PMC 바로가기 [Article Type] Neurology
The syndrome of inappropriate antidiuresis after vaccination against COVID-19: case reportCase Report Published on 2021-09-252022-10-28 Journal: BMC Infectious Diseases [Category] COVID-19, SARS, [키워드] absence acute respiratory syndrome Administered anorexia Antidiuresis C-reactive protein Case report Clinical finding condition coronavirus COVID-19 vaccination creatinine described diagnosed Diagnosis effective euvolemic explained expressed fatigue Fever fluids Health hyponatremia inappropriate antidiuresis laboratory investigation male medications mRNA-based vaccine Pain Patient patients receiving regimen resolved serum osmolality serum sodium SIADH sodium symptomatic syndrome systemic reaction the patient the vaccine therapy TSH urea Urine Urine chemistry vaccination vital sign weakness worsened worsening [DOI] 10.1186/s12879-021-06690-8 PMC 바로가기 [Article Type] Case Report
Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaquesResearch Article Published on 2021-09-222022-10-29 Journal: PLoS Pathogens [Category] COVID-19, SARS, [키워드] A.23.1 absence anatomical animal model animal models antibody Antibody-dependent cellular phagocytosis Antigen Beta binding Cellular immune response Control correlated Delta demonstrated develop dissemination DNA DNA vaccine effective Efficacy effort Electroporation elicited Epsilon Eta expressing Gamma highest humans humoral Humoral immunity Immunity in vitro include induce Intramuscular injection Lower respiratory tract mRNA-based vaccine nasal mucosa neutralized Neutralizing neutralizing antibody Neutralizing antibody titer Protective protective immune response Protein provide regimen responses rhesus rhesus macaque rhesus macaques robust SARS-CoV-2 SARS-COV-2 infection spike T cell response T cell responses tested the SARS-CoV-2 the Spike trials Vaccine variant virus virus level Wuhan-Hu-1 [DOI] 10.1371/journal.ppat.1009701 PMC 바로가기 [Article Type] Research Article
Challenges of Storage and Stability of mRNA-Based COVID-19 VaccinesReview Published on 2021-09-172022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acute respiratory syndrome Cambridge caused challenge coronavirus Coronavirus-2 country COVID-19 disease effective Emergency use ENhance global pandemic highly pathogenic Mainz Moderna MOST mRNA platform mRNA vaccine mRNA-based vaccine New York Pfizer Research RNA vaccine SARS-CoV-2 Spread stability storage temperature USA vaccination Vaccine Vaccines [DOI] 10.3390/vaccines9091033 PMC 바로가기 [Article Type] Review
The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing ImmunitymRNA-1273 백신은 기존 면역이 있거나 없는 개인에서 뚜렷한 프로필로 SARS-CoV-2에 대한 교차 변이 항체 반응을 유도합니다Immunology Published on 2021-09-032022-09-11 Journal: Frontiers in Immunology [Category] SARS, 변종, 진단, [키워드] analyzed antibody Antibody Response antibody subclasses benefit characterized Cohort comparable COVID-19 dose etiological agent humoral Humoral immunity IgA IgG1 IgG3 immunization individual individuals induce Kinetics lack mRNA mRNA vaccination mRNA vaccine mRNA-1273 mRNA-1273 vaccine mRNA-based vaccine mRNA-based vaccines naïve naïve individuals natural infection Neutralizing antibodies pre-existing immunity profile protective neutralizing antibodies protective neutralizing antibody recall receiving Receptor-binding domain recipient reduction regimen response SARS-CoV-2 SARS-COV-2 infection secondary immunization serum antibody spike receptor-binding domain subject subjects the receptor-binding domain triggered vaccination vaccine dose vaccine-induced antibody response vaccinee vaccinees variant variants variants of concern wild type [DOI] 10.3389/fimmu.2021.737083 PMC 바로가기 [Article Type] Immunology
Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine길랭-바레 증후군은 BNT162b2 mRNA COVID-19 백신의 수혜자 사이에서 드뭅니다Observational Study Published on 2021-09-012022-09-11 Journal: Clinical immunology (Orlando, Fla.) [Category] SARS, 임상, 치료기술, [키워드] Administered administration analyzed Autoimmune BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine causal link caution Cohort COVID-19 COVID-19 vaccine dose doses effective evaluated expected Guillain-barrè syndrome incidence mitigate mRNA mRNA vaccine mRNA vaccines mRNA-based vaccine mRNA-based vaccines nervous system occur Peripheral nervous system Preliminary data recipient recipients reduce reported syndrome Undetermined vaccine administration Vaccine hesitancy vaccine safety [DOI] 10.1016/j.clim.2021.108818 PMC 바로가기 [Article Type] Observational Study